RxDoctor Payments DataLook up a doctor →

Brett Kettelhut, MD

Allergy & Immunology · Omaha, NENPI 1538151204

Payments from drug & device makers

$192,762in general payments, 2019–2025

Across 583 payments — averaging $330.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$171K
  • AstraZeneca$6K
  • ARS Pharmaceuticals Operations, Inc.$4K
  • Sanofi$2K
  • GSK$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$994
  • plus $7K from 35 others

What the payments were for

  • Consulting fees$1,0115%
  • Speaking & faculty fees$3,80018%
  • Food & beverage$16,47077%
  • Education$1781%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$192,762 in reported general payments places this provider in the 65th percentile of 21 allergy & immunology providers in Nebraska.

See all allergy & immunology providers in Nebraska

Medicare billing

Part B allowed, 2024
$29,076
Medicare patients
25
Services billed
1,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →